ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 15309 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 15309; 2) Community: the network communities that were significantly associated with the response to NSC 15309; 3) Molecule: the relationships between components within communities and NSC 15309; 4) MDR: the compounds that were significantly associated with the NSC 15309.

NSC Compound Enrichment Correlation
NSC 720326 2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole 0.000497857311992526 0.32147659
NSC 176503 Fastigilin B 0.000572036815736153 0.69855982
NSC 623173 Null 0.000572036815736153 0.41993368
NSC 654236 Null 0.000572036815736153 0.29047705
NSC 668814 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative 0.000572036815736153 -0.42704817
NSC 17551 1,3-Propanedione, 1-(3-pyridinyl)-3-(2,4,6-trimethyl- phenyl)- 0.000601164336889762 0.16585094
NSC 683555 Camptothecin Derivative 0.000601164336889762 0.14121365
NSC 100880 Camptothecin 0.00103112124545269 0.030708136
NSC 741898 4-(2-pyridinyl)-5H-1,2,3-dithiazole-5-thione 0.0010311212454527 0.45514303
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.00140570135773563 0.73729116
Total:89  Current:2    [First] [Prev] [Next] [Last]